Immix Biopharma Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Immix Biopharma stock have an average target of 10.5, with a low estimate of 7.00 and a high estimate of 14. The average target predicts an increase of 404.81% from the current stock price of 2.08.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$10.5	$14	$14
Change	+236.54%	+404.81%	+573.08%	+573.08%

Analyst Ratings

The average analyst rating for IMMX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	1	1	1	1	2
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	1	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+236.54%	Jul 9, 2024
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+236.54%	Jul 1, 2024
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Reiterates $14	Strong Buy	Reiterates	$14	+573.08%	Aug 14, 2023
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Initiates $14	Strong Buy	Initiates	$14	+573.08%	Feb 22, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.95

from -0.89

EPS Next Year

-1.03

from -0.95

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	-	-	-	-	-	-	-	12.38M	49.12M	112.07M
Revenue Growth	-	-	-	-	-	-	-	-	296.62%	128.16%
EPS	-0.29	-0.34	-6.64	-0.59	-0.89	-0.95	-1.03	-0.38	0.85	2.78
EPS Growth	-	-	-	-	-	-	-	-	-	228.92%
Forward PE	-	-	-	-	-	-	-	-	2.46	0.75
No. Analysts	-	-	-	-	-	4	4	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	n/a	n/a	12.7M	50.6M	115.4M
Avg	n/a	n/a	12.4M	49.1M	112.1M
Low	n/a	n/a	11.9M	47.2M	107.7M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	-	-	-	308.3%	134.9%
Avg	-	-	-	296.6%	128.2%
Low	-	-	-	281.1%	119.2%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	-0.98	-1.06	-0.39	0.87	2.87
Avg	-0.95	-1.03	-0.38	0.85	2.78
Low	-0.91	-0.99	-0.36	0.81	2.68

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	-	-	238.6%
Avg	-	-	-	-	228.9%
Low	-	-	-	-	216.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.